ID: ALA4226854

Max Phase: Preclinical

Molecular Formula: C27H31NO2S

Molecular Weight: 433.62

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)c1ccc(-c2nc(-c3ccc4c(c3)C(C)(C)CCC4(C)C)c(C)s2)cc1

Standard InChI:  InChI=1S/C27H31NO2S/c1-7-30-25(29)19-10-8-18(9-11-19)24-28-23(17(2)31-24)20-12-13-21-22(16-20)27(5,6)15-14-26(21,3)4/h8-13,16H,7,14-15H2,1-6H3

Standard InChI Key:  ODEHUXTWZOLVMD-UHFFFAOYSA-N

Associated Targets(Human)

RARA Tclin Retinoic acid receptor alpha (1324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARB Tclin Retinoic acid receptor beta (1232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARG Tclin Retinoic acid receptor gamma (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 433.62Molecular Weight (Monoisotopic): 433.2076AlogP: 7.31#Rotatable Bonds: 4
Polar Surface Area: 39.19Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.09CX LogP: 8.32CX LogD: 8.32
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.40Np Likeness Score: -0.57

References

1. Haffez H, Chisholm DR, Tatum NJ, Valentine R, Redfern C, Pohl E, Whiting A, Przyborski S..  (2018)  Probing biological activity through structural modelling of ligand-receptor interactions of 2,4-disubstituted thiazole retinoids.,  26  (8): [PMID:29439915] [10.1016/j.bmc.2018.02.002]

Source